Target intelligence / Profile preview

Pseudomonas aeruginosa quorum-sensing regulator RhlR (RhlR)

Target
RhlR
Molecular classification
Transcription factor, LuxR-family protein, Receptor
01

Overview

The Pseudomonas aeruginosa quorum-sensing regulator RhlR is a cytoplasmic transcription factor that functions as a central node in the complex quorum-sensing (QS) network of this opportunistic pathogen (UniProt: P54292). It is a member of the LuxR family and is specifically activated by the cognate autoinducer N-butyryl-L-homoserine lactone (C4-HSL), which is produced by the RhlI synthase (PubMed: 23602554). Once bound to its ligand, RhlR dimerizes and binds to specific DNA sequences, known as lux boxes, to trigger the expression of numerous genes involved in virulence, including those for pyocyanin, rhamnolipids, and various proteases (PubMed: 11544221). This system is crucial for the establishment of chronic infections and the formation of robust biofilms, particularly in the lungs of cystic fibrosis patients and in hospital-acquired infections (PubMed: 25103157). Because RhlR controls the production of factors that damage host tissues and suppress immune responses, it is a high-priority target for anti-virulence therapy. Small-molecule antagonists, such as thiolactones, are being investigated for their ability to disrupt RhlR signaling, potentially offering a way to treat multi-drug resistant P. aeruginosa by attenuating its pathogenicity rather than inhibiting growth (PubMed: 23602554).

Other names
Regulatory protein RhlRRhlR transcription factorC4-HSL receptorTranscriptional regulator RhlR
02

Mechanism of action

Antagonism of the RhlR receptor to prevent binding of the autoinducer C4-HSL, thereby inhibiting the transcription of virulence-associated genes and biofilm development (PubMed: 23602554).

03

Biological functions

Quorum sensingRegulation of gene expressionVirulence factor productionBiofilm formationBacterial communication
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsis
05

Safety considerations

Potential for dysbiosis of commensal floraDevelopment of resistance to anti-virulence agentsBioavailability in thick mucus (e.g., in cystic fibrosis lungs)
06

Interacting drugs

mBTL (meta-bromo-thiolactone) (PubMed: 23602554)

3 more in the full profile.

07

Biomarkers

Pyocyanin levelsRhamnolipid productionC4-HSL concentrationBiofilm density

Beyond the preview

Go deeper on Pseudomonas aeruginosa quorum-sensing regulator RhlR (RhlR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa quorum-sensing regulator RhlR (RhlR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call